Loading…
Lobbying Spend
—
Filings
4
Firms Hired
1
Active Period
2025
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · third_quarter · Firm: HOLLAND & KNIGHT LLP
Over-the-counter (OTC) drug and food safety and nutrition issues; OTC monograph User Fee Act (OMUFA) reauthorization; Fiscal Year 2026 appropriations for the Food and Drug Administration (FDA) (H.R. 4121 and S. 2256); FDA rulemaking on ultraprocessed food.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 4121
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · third_quarter · Firm: HOLLAND & KNIGHT LLP
Over-the-counter (OTC) drug and food safety and nutrition issues; OTC monograph User Fee Act (OMUFA) reauthorization; Fiscal Year 2026 appropriations for the Food and Drug Administration (FDA) (H.R. 4121 and S. 2256); FDA rulemaking on ultraprocessed food.
Client expense: — · Firm income: $60,000
Matched citations: S. 2256
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · second_quarter · Firm: HOLLAND & KNIGHT LLP
Over-the-counter (OTC) drug and food safety and nutrition issues; OTC monograph User Fee Act (OMUFA) reauthorization; Fiscal Year 2026 appropriations for the Food and Drug Administration (FDA) (H.R. 4121 and S. 2256).
Client expense: — · Firm income: $60,000
Matched citations: H.R. 4121
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · second_quarter · Firm: HOLLAND & KNIGHT LLP
Over-the-counter (OTC) drug and food safety and nutrition issues; OTC monograph User Fee Act (OMUFA) reauthorization; Fiscal Year 2026 appropriations for the Food and Drug Administration (FDA) (H.R. 4121 and S. 2256).
Client expense: — · Firm income: $60,000
Matched citations: S. 2256
Source: Senate LDA